div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader042vdocumentinreader042viewer20220412125dd140c2d6be591ccb64f48dhtml5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: ATLAS VENTURE TRANSFORMING CANCER TREATMENT o … · ATLAS VENTURE TRANSFORMING CANCER TREATMENT o SURFACE ONCOLOGY *FACE NaSdaq SURFACE ONCOLOGY THE TUMOR MICROENVIRONMENT COMPANY src=https:reader042vdocumentinreader042viewer20220412125dd140c2d6be591ccb64f48dhtml5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdiv class=annotationa href=https:atlasventurecom rel=ugc nofollow target=_blankhttps:atlasventurecomadiv div class=annotationa href=https:atlasventurecom rel=ugc nofollow target=_blankhttps:atlasventurecomadiv div class=annotationa href=https:twittercomatlasventure rel=ugc nofollow target=_blankhttps:twittercomatlasventureadiv div class=annotationa href=https:investorssurfaceoncologycomnews-releasesnews-release-detailssurface-oncology-announces-closing-1195-million-aggregate rel=ugc nofollow target=_blankhttps:investorssurfaceoncologycomnews-releasesnews-release-detailssurface-oncology-announces-closing-1195-million-aggregateadiv div class=annotationa href=https:investorsunumrxcomnews-releasesnews-release-detailsunum-therapeutics-announces-closing-initial-public-offering-and rel=ugc nofollow target=_blankhttps:investorsunumrxcomnews-releasesnews-release-detailsunum-therapeutics-announces-closing-initial-public-offering-andadiv div class=annotationa href=https:atlasventurecom rel=ugc nofollow target=_blankhttps:atlasventurecomadivdiv